23andMe Data Paves Way For First-of-its-Kind Cancer Drug Development Business Data aggregated by 23andMe was leveraged into the development of 23ME-00610, a cancer-fighting drug with promising early clinical results.
Early Detection of Alzheimer’s May be Possible Through Simple Blood Tests Investing Less invasive, early stage Alzheimer’s blood tests may be on the horizon — with big implications for future treatments of the disease.
DOJ Arrests Telehealth Company Done ADHD’s Top-Ranking Executives NEWS The case against Done ADHD involves a byzantine interplay and finger pointing between pharmaceutical manufactures and government regulators.
